T-cell prolymphocytic leukemia medical therapy

T-cell prolymphocytic leukemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating T-cell Prolymphocytic Leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
T-cell prolymphocytic leukemia medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of T-cell prolymphocytic leukemia medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on T-cell prolymphocytic leukemia medical therapy
CDC on T-cell prolymphocytic leukemia medical therapy
T-cell prolymphocytic leukemia medical therapy in the news
Blogs on T-cell prolymphocytic leukemia medical therapy
Directions to Hospitals Treating T-cell prolymphocytic leukemia
Risk calculators and risk factors for T-cell prolymphocytic leukemia medical therapy

Medical Therapy

TPLL responds better when combinations of chemotherapy drugs are used. Some combinations that may be used are:

• CVP – cyclophosphamide (Cytoxan, Procytox), vincristine (Oncovin) and prednisone (Deltasone)

• CHOP – cyclophosphamide, doxorubicin (Adriamycin), vincristine and prednisone

Other chemotherapy drugs, called purine analogues, are often used to treat PLL and seem to be effective:

• [[Fludarabine
• Cladribine
• Pentostatin